Interindividual Genetic Differences Drive Discordance Between Serum Calcidiol and Calcitriol Concentrations in Females
Vitamin D insufficiency (VDI) is primarily determined by serum levels of calcidiol, which serves as a biomarker for the less abundant but most potent bioactive metabolite, calcitriol. However, population studies often show discordance between calcidiol and calcitriol. Here, a genetically diverse population of 7 inbred mouse strains was used to investigate the role of interindividual genetic differences in driving calcidiol-to-calcitriol discordance under vitamin D sufficient (VDS) vs depleted (VDD) conditions. We found high interstrain variability in calcitriol that was discordant with calcidiol under VDS and VDD conditions. However, under VDS conditions, stratification by calcitriol level revealed that strains with serum calcitriol >60 pM (HighC) exhibited the expected positive calcidiol-to-calcitriol association, whereas strains with low calcitriol (<60 pM, LowC) did not. Thus, discordance under VDS was driven by genetically divergent strains with LowC. Discordance under VDD was not associated with LowC. LowC was not caused by increased calcitriol degradation or by transcriptional dysregulation of canonical vitamin D metabolism enzymes. Instead, LowC strains exhibited low renal expression of Lrp2 (megalin), the primary transporter required for renal calcitriol production. LowC strains also exhibited reduced renal expression of the vitamin D receptor (Vdr) and several target genes, demonstrating impaired vitamin D signaling. These findings reveal novel, naturally occurring genetic determinants of VDI that function by disrupting calcitriol production and signaling in a manner that cannot be predicted by calcidiol levels. Cross-species conservation of this phenomenon would have important implications for clinical management of VDI and related disease risks across genetically diverse populations.
Authors
- Carolina Vieira Campos (ORCID: https://orcid.org/0000-0002-6512-1159)
- M. Warren (ORCID: https://orcid.org/0000-0003-0378-929X)
- V. Saroja Voruganti (ORCID: https://orcid.org/0000-0002-8704-4529)
- James C. Fleet (ORCID: https://orcid.org/0000-0002-0142-9517)
- Bruce D. Hammock (ORCID: https://orcid.org/0000-0003-1408-8317)
- Jing Xue (ORCID: https://orcid.org/0000-0002-0146-3459)
- Michael B. Whalen (ORCID: https://orcid.org/0000-0001-7300-8511)
- Megan M. Knuth (ORCID: https://orcid.org/0000-0001-8697-6036)
- Chun-Feng Niu
- Elizabeth K Hutchins (ORCID: https://orcid.org/0009-0003-9503-9046)
- Debin Wan
- Folami Ideraabdullah (ORCID: https://orcid.org/0000-0002-5754-2615)
- Rafiou Agoro (ORCID: https://orcid.org/0000-0002-5461-7685)
Institutions
- University of North Carolina at Chapel Hill (US)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- David H. Murdock Research Institute (US)
- Jackson Laboratory (US)
- UCSF Helen Diller Family Comprehensive Cancer Center (US)
- UNC Lineberger Comprehensive Cancer Center
- University of California, Davis (US)
- The University of Texas at Austin (US)
Publication Details
- Journal
- Endocrinology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1210/endocr/bqaf138
- Citations
- 1
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Nutrition Obesity Research Center, University of North Carolina
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Environmental Health Sciences